Nvidia CEO Jensen Huang's rejection of the AI bubble narrative seemed to reassured investors initially, but their concerns ...

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you ...

In the ultra-competitive world of cancer medicines, biotech company Summit Therapeutics is a relative minnow, with no revenue or approved drugs. But recent news around its most promising drug nearly ...

Leveraged exchange-traded funds (ETFs), such as ProShares UltraPro QQQ (TQQQ) and ProShares Ultra S&P 500 (SSO) are tempting ...

Worried that the tech-stock sell-off in recent days is the beginning of the end for the AI boom? Don't be, says Neuberger ...

Allspring Global Investments Holdings LLC lowered its holdings in Abrdn Life Sciences Investors (NYSE:HQL – Free Report) by 40.8% in the fourth quarter, according to its most recent disclosure with ...